Cargando…
The quest for the Holy Grail: a disease-modifying osteoarthritis drug
The unfortunate story of the matrix metalloproteinase inhibitor PG116800, which had no effect on the osteoarthritic process but had unexpected side effects, highlights the following. First, reality does not always match the theory. Second, cell biology data must be interpreted within the context of...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246245/ https://www.ncbi.nlm.nih.gov/pubmed/18096086 http://dx.doi.org/10.1186/ar2335 |